Nanoform Finland Oyj (NANOFH.HE)

EUR 1.29

(2.7%)

Inventory Summary of Nanoform Finland Oyj

Nanoform Finland Oyj's latest annual inventory in 2023 was 218.26 Thousand EUR , up 3570.79% from previous year.
Nanoform Finland Oyj's latest quarterly inventory in 2024 Q2 was 261 Thousand EUR , up 0.77% from previous quarter.
Nanoform Finland Oyj reported annual inventory of 5946.00 EUR in 2022, up 594700.0% from previous year.
Nanoform Finland Oyj reported annual inventory of -1.00 EUR in 2021, down -100.01% from previous year.
Nanoform Finland Oyj reported quarterly inventory of 259 Thousand EUR for 2024 Q1, up 18.66% from previous quarter.
Nanoform Finland Oyj reported quarterly inventory of 84 Thousand EUR for 2023 Q2, up 25.37% from previous quarter.

Annual Inventory Chart of Nanoform Finland Oyj (2023 - 2016)

Historical Annual Inventory of Nanoform Finland Oyj (2023 - 2016)

Year	Inventory	Inventory Growth
2023	218.26 Thousand EUR	3570.79%
2022	5946.00 EUR	594700.0%
2021	-1.00 EUR	-100.01%
2020	16.6 Thousand EUR	0.0%
2019	- EUR	100.0%
2018	- EUR	-100.0%
2017	992.00 EUR	0.0%
2016	- EUR	0.0%

Year	Inventory	Inventory Growth
2024 Q2	261 Thousand EUR	0.77%
2024 Q1	259 Thousand EUR	18.66%
2023 Q2	84 Thousand EUR	25.37%
2023 FY	218.26 Thousand EUR	3570.79%
2023 Q4	218.26 Thousand EUR	52.63%
2023 Q3	143 Thousand EUR	70.24%
2023 Q1	67 Thousand EUR	1026.81%
2022 Q1	1.12 Million EUR	112799900.0%
2022 Q4	5946.00 EUR	-99.61%
2022 Q3	1.54 Million EUR	153999900.0%
2022 Q2	1.00 EUR	-100.0%
2022 FY	5946.00 EUR	594700.0%
2021 FY	-1.00 EUR	-100.01%
2021 Q4	1.00 EUR	100.0%
2021 Q3	-710 Thousand EUR	-71000100.0%
2021 Q2	1.00 EUR	-100.0%
2021 Q1	426 Thousand EUR	42599900.0%
2020 FY	16.6 Thousand EUR	0.0%
2020 Q2	660 Thousand EUR	65999900.0%
2020 Q4	1.00 EUR	0.0%
2020 Q3	1.00 EUR	-100.0%
2020 Q1	1.00 EUR	100.0%
2019 Q4	-33.98 Thousand EUR	0.0%
2019 Q1	- EUR	0.0%
2019 FY	- EUR	100.0%
2018 FY	- EUR	-100.0%
2017 FY	992.00 EUR	0.0%
2016 FY	- EUR	0.0%

Peer Inventory Comparison of Nanoform Finland Oyj

Name	Inventory	Inventory Difference
Biohit Oyj	900 Thousand EUR	75.748%
Herantis Pharma Oyj	-237.97 Thousand EUR	191.719%